17th Bleeding and Thrombosing Diseases Conference and Workshop
October 6‒8, 2021 | Via livestream
- Mayo Clinic Division of Hematology, Department of Internal Medicine
- Special Coagulation Laboratory, Division of Hematopathology, Department of Laboratory Medicine and Pathology
- Mayo Clinic Laboratories
This Mayo Clinic conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by time for participant questions.
This program is designed for clinicians, pathologists, scientists, nurse practitioners and physician assistants, nurses, and laboratory technologists whose practices include bleeding and thrombosing diseases.
Upon completion of the conference, participants should be able to:
- Summarize clinical features and laboratory evaluation of congenital and acquired bleeding disorders including hemophilia A and B, hereditary platelet disorders, and von Willebrand disease.
- Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, lupus anticoagulant, and antiphospholipid syndrome.
- Explain key features of treatment of venous thromboembolism (VTE) including options for therapy and care for specialized patient populations with VTE (i.e., cancer patients).
- Discuss features of the direct oral anticoagulant (DOAC) drugs including situations where use is appropriate versus not recommended, and options for DOAC reversal.
Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in the courses.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared with ABIM through PARS.
American Academy of Family Physicians
The AAFP has reviewed Bleeding and Thrombosing Diseases Conference and Workshop and deemed it acceptable for up to 18.00 In-Person, Live (could include online) AAFP Prescribed credit. Term of Approval is from 10/06/2021 to 10/08/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 18 P.A.C.E.® contact hours.
State of California
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 18 contact hours.
State of Florida
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General-Hematology credit. This program has been approved for 18 contact hours.
Certificate of attendance — Other health care professionals
A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state boards, specialty societies, or other professional associations.
Attendees should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™ from the sponsor of this activity.
Physicians/Scientists - $525
Residents/Fellows/Allied Health - $450
If you also registered for the 2021 Non-Malignant Hematology Conference hosted by Mayo Clinic Laboratories, you are eligible for a $100 credit on the price of this conference.
Please contact email@example.com or call 507-284-3156 to access this credit.
If you cancel your participation in this conference on or before September 7, 2021, your registration fee, less a $75 administrative fee, will be refunded. Mayo Clinic Laboratories Education Department must receive written notification of your cancellation. No refunds will be made after September 7.
Mayo Clinic Laboratories reserves the right to cancel or postpone any conference due to unforeseen circumstances. In the unlikely event Mayo Clinic Laboratories must cancel or postpone this conference, Mayo Clinic Laboratories will refund the registration fee but is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
For companies interested in exhibit opportunities at this conference, please contact Janice Bergquist at firstname.lastname@example.org or 507-266-0430.
Contact us: email@example.com